Director/PDMR Shareholding
Eco Animal Health Group Plc
Issue of Share Options
ECO Animal Health Group plc
(“ECO†or the “Companyâ€)
21st December 2015
The Company announces that on 18th December 2015, the Board granted new options to certain Directors and Non-Executive Directors of the Company under the Company’s executive share option scheme (“New Optionsâ€). The New Options will vest on 18th December 2018 and have been granted as follows:
Director | Â | Number of options granted | Â | Exercise price | |
Marc Loomes | 350,000 | £3.125 | |||
Brett Clemo | 250,000 | £3.125 | |||
Julia Trouse | 50,000 | £3.125 | |||
Kevin Stockdale | 50,000 | £3.125 |
The aggregate 700,000 New Options issued represents approximately 1.09 per cent of the Company’s existing issued share capital. Following the issue, the Company’s total voting rights remains unchanged at 63,969,135 ordinary shares of 5p each.
Enquiries
ECO Animal Health Group plc
Peter Lawrence, Executive Chairman 020 8336 6190
Marc Loomes, CEO 020 8447 8899
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Adrian Trimmings 020 7418 8900
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151221005409/en/